CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.93%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.4B
AUM Growth
-$406M
(-2.7%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
24.27%
Holding
963
New
98
Increased
340
Reduced
353
Closed
82
Top Buys
| 1 |
ZTO Express
ZTO
|
$42.9M |
| 2 |
STKL
SunOpta
STKL
|
$39.6M |
| 3 |
Kanzhun
BZ
|
$36.9M |
| 4 |
JPMorgan Chase
JPM
|
$35M |
| 5 |
Lantheus
LNTH
|
$30.3M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$85.2M |
| 2 |
Microsoft
MSFT
|
$60.8M |
| 3 |
Veru
VERU
|
$53.9M |
| 4 |
Procter & Gamble
PG
|
$48.4M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 30.95% |
| 2 | Technology | 26.5% |
| 3 | Financials | 9.1% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Exelon
EXC
$43.9B
| $12.5M | 0.09% |
324,772
+220,620
| +212% | +$8.51M |
|
227
Arvinas
ARVN
$575M
| $12.4M | 0.09% |
494,947
-39,055
| -7% | -$982K |
|
228
PTC Therapeutics
PTCT
$4.55B
| $12.4M | 0.09% |
277,652
+75,000
| +37% | +$3.34M |
|
229
IDEX
IEX
$12.4B
| $12.4M | 0.09% |
58,124
+42,841
| +280% | +$9.11M |
|
230
Everest Group
EG
$14.3B
| $12.3M | 0.09% |
37,285
-22,633
| -38% | -$7.46M |
|
231
Revolution Medicines
RVMD
$7.57B
| $12.1M | 0.08% |
606,332
-126,173
| -17% | -$2.52M |
|
232
Jefferies Financial Group
JEF
$13.1B
| $11.9M | 0.08% |
407,713
-119,172
| -23% | -$3.48M |
|
233
O-I Glass
OI
$1.97B
| $11.7M | 0.08% |
561,385
-383,217
| -41% | -$8.01M |
|
234
Illinois Tool Works
ITW
$77.6B
| $11.7M | 0.08% |
52,096
-81,803
| -61% | -$18.3M |
|
235
Moody's
MCO
$89.5B
| $11.6M | 0.08% |
41,085
+1,569
| +4% | +$442K |
|
236
Walmart
WMT
$801B
| $11.6M | 0.08% |
255,798
+22,464
| +10% | +$1.02M |
|
237
American Tower
AMT
$92.9B
| $11.5M | 0.08% |
61,360
-3,000
| -5% | -$564K |
|
238
Micron Technology
MU
$147B
| $11.5M | 0.08% |
206,382
+37,145
| +22% | +$2.06M |
|
239
Booking.com
BKNG
$178B
| $11.3M | 0.08% |
4,628
+1,347
| +41% | +$3.29M |
|
240
Guardant Health
GH
$7.5B
| $11.2M | 0.08% |
521,182
+61,538
| +13% | +$1.33M |
|
|
KRTX
241
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $11.2M | 0.08% |
67,201
-15,000
| -18% | -$2.51M |
|
242
Mersana Therapeutics
MRSN
$34M
| $11.2M | 0.08% |
118,514
+10,800
| +10% | +$1.02M |
|
243
ResMed
RMD
$40.6B
| $11.2M | 0.08% |
55,528
+3,053
| +6% | +$615K |
|
244
T-Mobile US
TMUS
$284B
| $11.1M | 0.08% |
82,895
-23,661
| -22% | -$3.15M |
|
245
Crown Holdings
CCK
$11B
| $10.9M | 0.08% |
143,823
-1,415
| -1% | -$108K |
|
246
ConocoPhillips
COP
$116B
| $10.9M | 0.08% |
119,845
+13,469
| +13% | +$1.23M |
|
247
Zoetis
ZTS
$67.9B
| $10.9M | 0.08% |
71,302
-21,624
| -23% | -$3.31M |
|
248
LKQ Corp
LKQ
$8.33B
| $10.8M | 0.08% |
207,567
-3,282
| -2% | -$171K |
|
249
Replimune Group
REPL
$494M
| $10.8M | 0.07% |
662,922
| – | – |
|
250
Deere & Co
DE
$128B
| $10.6M | 0.07% |
27,935
+2,602
| +10% | +$989K |
|